.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Oral presentation
O56

Irf3 and Irf7 are crucial factors for controlling a tumor-promoting epigenetic program

Appointment

Date: Sa, 17/02

Time: 13:00 – 13:10

Talk time: 8 Min.

Discussion time: 2 Min.

Location / Stream:

Plenary

Session

Basic science III

Topic

Pancreatic cancer

Authors

Lisa Fahr (Munich / DE), Simone Benitz (Detroit, MI / US), Tobias Straub (Munich / DE), Jurik Mutter (Munich / DE), Hannah Lisiecki (Munich / DE), Prof. Dr. Ujjwal M. Mahajan (Munich / DE), PD Dr. Georg Beyer (Munich / DE), Prof. Dr. Katja Steiger (Munich / DE), Andrea Terrasi (Munich / DE), Gunnar Schotta (Munich / DE), Axel Imhof (Munich / DE), Kirsten Lauber (Munich / DE), Prof. Dr. Med Jörg Kleeff (Halle / DE), Prof. Dr. Christoph W. Michalski (Ulm / DE), Prof. Dr. Julia Mayerle (Munich / DE), PD Dr. Ivonne Regel (Munich / DE)